These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15152143)

  • 21. Association between completeness of percutaneous coronary revascularization and postprocedure outcomes.
    McLellan CS; Ghali WA; Labinaz M; Davis RB; Galbraith PD; Southern DA; Shrive FM; Knudtson ML;
    Am Heart J; 2005 Oct; 150(4):800-6. PubMed ID: 16209985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome.
    Hassanin A; Brener SJ; Lansky AJ; Xu K; Stone GW
    EuroIntervention; 2015 Jul; 11(3):293-300. PubMed ID: 25136882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
    Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
    Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
    Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Percutaneous and surgical revascularization in acute coronary syndromes without persistent ST segment elevation. One-year outcome of 361 patients assigned to early invasive strategy].
    Szyguła-Jurkiewicz B; Wilczek K; Przybylski R; Pacholewicz J; Trzeciak P; Styn T; Zembala M; Poloński L
    Przegl Lek; 2004; 61(12):1295-300. PubMed ID: 15850316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial.
    Vieira RD; Hueb W; Gersh BJ; Lima EG; Pereira AC; Rezende PC; Garzillo CL; Hueb AC; Favarato D; Soares PR; Ramires JA; Kalil Filho R
    Circulation; 2012 Sep; 126(11 Suppl 1):S158-63. PubMed ID: 22965977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary revascularization strategy for ST elevation myocardial infarction with multivessel disease: experience and results at 1-year follow-up.
    Mohamad T; Bernal JM; Kondur A; Hari P; Nelson K; Niraj A; Badheka A; Hassna S; Kiernan T; Elder MD; Gardi D; Schreiber T
    Am J Ther; 2011; 18(2):92-100. PubMed ID: 20027110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trial.
    Valgimigli M; Dawkins K; Macaya C; de Bruyne B; Teiger E; Fajadet J; Gert R; De Servi S; Ramondo A; Wittebols K; Stoll HP; Rademaker TA; Serruys PW
    J Am Coll Cardiol; 2007 Jan; 49(4):431-41. PubMed ID: 17258088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of culprit versus multivessel PCI in patients with multivessel coronary artery disease presenting with ST-elevation myocardial infarction complicated by shock.
    Cavender MA; Rajeswaran J; DiPaola L; Houghtaling P; Kiernan MS; Rassi AN; Menon V; Whitlow PW; Ellis SG; Shishehbor MH
    J Invasive Cardiol; 2013 May; 25(5):218-24. PubMed ID: 23645045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies: Insights from the REAL registry.
    Manari A; Varani E; Guastaroba P; Menozzi M; Valgimigli M; Menozzi A; Magnavacchi P; Franco N; Marzocchi A; Casella G
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):912-22. PubMed ID: 24403174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction.
    Chen LY; Lennon RJ; Grantham JA; Berger PB; Mathew V; Singh M; Holmes DR; Rihal CS
    Am J Cardiol; 2005 Feb; 95(3):349-54. PubMed ID: 15670543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cohort study of risk factors and clinical outcome predictors for patients presenting with unstable angina and non ST segment elevation myorardial infraction undergoing coronary intervention.
    Chong E; Shen L; Tan HC; Poh KK
    Med J Malaysia; 2011 Aug; 66(3):249-52. PubMed ID: 22111450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease.
    Bangalore S; Kumar S; Poddar KL; Ramasamy S; Rha SW; Faxon DP
    Am J Cardiol; 2011 May; 107(9):1300-10. PubMed ID: 21349487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Culprit only versus complete coronary revascularization during primary PCI.
    Qarawani D; Nahir M; Abboud M; Hazanov Y; Hasin Y
    Int J Cardiol; 2008 Jan; 123(3):288-92. PubMed ID: 17428557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes.
    Rathod KS; Koganti S; Jain AK; Astroulakis Z; Lim P; Rakhit R; Kalra SS; Dalby MC; O'Mahony C; Malik IS; Knight CJ; Mathur A; Redwood S; Sirker A; MacCarthy PA; Smith EJ; Wragg A; Jones DA
    J Am Coll Cardiol; 2018 Oct; 72(17):1989-1999. PubMed ID: 30336821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002.
    Hoye A; van Domburg RT; Sonnenschein K; Serruys PW
    Eur Heart J; 2005 Dec; 26(24):2630-6. PubMed ID: 16183693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Provisional stenting for multivessel PCI.
    Han B; Liu L; Aboud M; Nahir M; Hasin Y
    Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.